Portal de Periódicos da CAPES

Inhaled heliox does not benefit ED patients withmoderate to severe asthma

2000; Elsevier BV; Volume: 18; Issue: 4 Linguagem: Inglês

10.1053/ajem.2000.7365

1532-8171

Todd A. Dorfman, Eric R. Shipley, John H. Burton, Paul R. Jones, Stephen A. Mette,

Respiratory Support and Mechanisms

Helium and oxygen gas mixtures (heliox) have become an area of renewed interest in pediatric emergency and critical care for the treatment of acute asthma exacerbations and bronchiolitis. After a review of recent literature on heliox, this article will provide an overview of delivery techniques. This article will primarily focus on heliox inhalation therapy and heliox-driven nebulizer therapy for acute asthma exacerbations. The emergence of heliox inhalation therapy for acute viral bronchiolitis will also be addressed.